Determination of a measure of a glycation end-product or disease state using tissue fluorescence preferentially from the dermis
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61B-005/00
A61B-005/1455
출원번호
US-0417463
(2006-05-03)
등록번호
US-8121671
(2012-02-21)
발명자
/ 주소
Hull, Edward L.
Ediger, Marwood Neal
Brown, Christopher D.
Maynard, John D.
Johnson, Robert D.
출원인 / 주소
VeraLight, Inc.
대리인 / 주소
Grafe, V. Gerald
인용정보
피인용 횟수 :
1인용 특허 :
40
초록▼
A method of determining a measure of a tissue state (e.g., glycation end-product or disease state) in an individual. A portion of the tissue of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical with the tissue responsive to the ex
A method of determining a measure of a tissue state (e.g., glycation end-product or disease state) in an individual. A portion of the tissue of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical with the tissue responsive to the excitation light is detected. The detected light can be combined with a model relating fluorescence with a measure of tissue state to determine a tissue state. The invention can comprise single wavelength excitation light, scanning of excitation light (illuminating the tissue at a plurality of wavelengths), detection at a single wavelength, scanning of detection wavelengths (detecting emitted light at a plurality of wavelengths), and combinations thereof. The invention also can comprise correction techniques that reduce determination errors due to detection of light other than that from fluorescence of a chemical in the tissue. For example, the reflectance of the tissue can lead to errors if appropriate correction is not employed. The invention can also comprise a variety of models relating fluorescence to a measure of tissue state, including a variety of methods for generating such models. Other biologic information can be used in combination with the fluorescence properties to aid in the determination of a measure of tissue state. The invention also comprises apparatuses suitable for carrying out the method, including appropriate light sources, detectors, and models (for example, implemented on computers) used to relate detected fluorescence and a measure of tissue state.
대표청구항▼
1. A method of determining a tissue state of the tissue of an individual, comprising: (a) illuminating a portion of the tissue of the individual with excitation light;(b) detecting light emitted from the tissue by fluorescence of a chemical within the tissue such that light that has interacted with
1. A method of determining a tissue state of the tissue of an individual, comprising: (a) illuminating a portion of the tissue of the individual with excitation light;(b) detecting light emitted from the tissue by fluorescence of a chemical within the tissue such that light that has interacted with the dermis is preferentially detected relative to light from other layers within the tissue, wherein detecting light emitted from the tissue comprises:(i) determining a first tissue reflectance characteristic at an excitation light wavelength;(ii) detecting light returned from the tissue in response to illumination at the excitation wavelength such that light that has interacted with the dermis is preferentially detected relative to light that has not interacted with the dermis;(iii) determining a corrected fluorescence measurement from the detected light and the first tissue reflectance characteristic;(c) determining the tissue state from the detected light and a model relating fluorescence and a tissue state, wherein determining a tissue state comprises determining the tissue state from the corrected fluorescence measurement and a model relating fluorescence and tissue state. 2. A method as in claim 1, wherein detecting light emitted from the tissue comprises: Determining a second tissue reflectance characteristic at a detection wavelength;Detecting light at the detection wavelength returned from the skin in response to illumination at the excitation wavelength such that light that has interacted with the dermis is preferentially detected relative to light that has not interacted with the dermis;Determining a corrected fluorescence measurement from the detected light and the first and second tissue reflectance characteristics. 3. A method as in claim 1, wherein determining a tissue reflectance characteristic comprises: illuminating the tissue with reflectance illumination light having the excitation wavelength;detecting reflectance light having the excitation wavelength reflected from the tissue, using the same detector as used to detect light returned from the tissue; andestablishing a tissue reflectance characteristic from a relationship between the reflectance illumination light and the reflectance light. 4. A method as in claim 1, wherein determining a tissue reflectance characteristic comprises: illuminating a portion of the tissue with reflectance illumination light having an excitation wavelength;detecting reflectance light having the excitation wavelength reflected from the portion of the tissue; andestablishing a tissue reflectance characteristic from a relationship between the reflectance illumination light and the reflectance light. 5. A method as in claim 1, wherein the tissue state determination is substantially insensitive to the present glucose concentration in the subject. 6. A method as in claim 5, wherein the tissue state determination is substantially insensitive to the time since the individual's last meal. 7. A method as in claim 1 wherein illuminating a portion of the tissue comprises directing light to a surface of the tissue using a probe comprising a plurality of light launch sites disposed in a symmetrical pattern. 8. A method as in claim 7, wherein illuminating a portion of the tissue comprises directing light to the surface of the tissue using a probe comprising a plurality of optical fibers whose ends define launch sites. 9. A method as in claim 7, wherein the symmetrical pattern comprises at least two different inter-site spacings. 10. A method as in claim 1 wherein illuminating a portion of the tissue comprises directing light to the surface of the tissue using a probe comprising a plurality of optical fibers, wherein the optical fibers are spaced apart from each other. 11. A method as in claim 1 (i) further comprising providing probe comprising a plurality of light launch sites and a plurality of light collection sites, wherein a majority of the light collection sites are in optical communication with two or more light launch sites; and (ii) wherein illuminating a portion of the tissue comprises directing light to a surface of the tissue using the probe; and (iii) wherein detecting light emitted from the tissue comprises using the probe to collect light. 12. A method as in claim 1 (i) further comprising providing probe comprising a plurality of light launch sites and a plurality of light collection sites, wherein the light collection sites and light launch sites are disposed in a two dimensional arrangement in a surface substantially parallel to the surface of the tissue; and (ii) wherein illuminating a portion of the tissue comprises directing light to a surface of the tissue using the probe; and (iii) wherein detecting light emitted from the tissue comprises using the probe to collect light. 13. A method of determining a tissue state of the tissue of an individual, comprising: (a) illuminating a portion of the tissue of the individual with excitation light;(b) detecting light emitted from the tissue by fluorescence of a chemical within the tissue such that light that has interacted with the dermis is preferentially detected relative to light from other layers within the tissue, wherein detecting light emitted from the tissue comprises:(i) determining a tissue reflectance characteristic at a detection wavelength;(ii) detecting light at the detection wavelength returned from the tissue in response to illumination such that light that has interacted with the dermis is preferentially detected relative to light that has not interacted with the dermis;(iii) determining a corrected fluorescence measurement from the detected light and the tissue reflectance characteristic;(c) determining the tissue state from the detected light and a model relating fluorescence and a tissue state, wherein determining a tissue state comprises determining the tissue state from the corrected fluorescence measurement and a model relating fluorescence and tissue state. 14. A method as in claim 13, wherein determining a tissue reflectance characteristic comprises: illuminating the tissue with reflectance illumination light having a wavelength the same as the detection wavelength;detecting reflectance light having the detection wavelength reflected from the tissue, using the same detector as used to detect light returned from the tissue; andestablishing a tissue reflectance characteristic from a relationship between the reflectance illumination light and the reflectance light. 15. A method as in claim 13, wherein determining a tissue reflectance characteristic comprises: illuminating the portion of the tissue with reflectance illumination light having a wavelength the same as the detection wavelength;detecting reflectance light having the detection wavelength reflected from the portion of the tissue; andestablishing a tissue reflectance characteristic from a relationship between the reflectance illumination light and the reflectance light. 16. A method as in claim 13, wherein the tissue state determination is substantially insensitive to the present glucose concentration in the individual. 17. A method as in claim 16, wherein the tissue state determination is substantially insensitive to the time since the individual's last meal. 18. A method as in claim 13, wherein illuminating a portion of the tissue comprises directing light to a surface of the tissue using a probe comprising a plurality of light launch sites disposed in a symmetrical pattern. 19. A method as in claim 18, wherein the probe comprises a plurality of optical fibers whose ends define launch sites. 20. A method as in claim 18, wherein the symmetrical pattern comprises at least two different inter-site spacings. 21. A method as in claim 13, wherein illuminating a portion of the tissue comprises directing light to a surface of the tissue using a probe comprising a plurality of optical fibers, wherein the optical fibers are spaced apart from each other. 22. A method as in claim 13, wherein illuminating a portion of the tissue comprises directing light to a surface of the tissue using a probe comprising a plurality of light launch sites and a plurality of light collection sites, wherein a majority of the light collection sites are in optical communication with two or more light launch sites. 23. A method of determining a tissue state of the tissue of an individual, comprising: (a) illuminating a portion of the tissue of the individual with excitation light;(b) detecting light emitted from the tissue by fluorescence of a chemical within the tissue such that light that has interacted with the dermis is preferentially detected relative to light from other layers within the tissue;(c) acquiring biologic information relating to the individual, wherein the biologic information comprises gender of the individual, height of the individual, weight of the individual, waist circumference of the individual, history of disease in the individual's family, history of gestational diabetes, history of polycystic ovary syndrome, systolic blood pressure, diastolic blood pressure, ethnicity, skin melanin content, smoking history of the individual, blood HDL cholesterol level of the subject, blood LDL cholesterol level of the subject, blood triglycerides level of the subject, or a combination thereof;(d) determining the tissue state from the information, the detected light, and a model relating biologic information, fluorescence and tissue state. 24. A method of determining a tissue state in an individual, comprising: Establishing an interface between an optical system and a portion of the tissue of the individual;Determining a relationship of illumination light at an excitation wavelength and the response of primarily the dermis of the skin at a detection wavelength for each of a plurality of pairings of excitation wavelength and detection wavelength;Determining a tissue reflectance property of the skin at each of the illumination wavelengths and at each of the detection wavelengths;Determining a measure of the intrinsic fluorescence of the skin from the relationships of illumination light and detected light and the tissue reflectance properties;Determining the tissue state of the individual from the intrinsic fluorescence using a model relating intrinsic fluorescence and tissue state. 25. A method as in claim 24, further comprising acquiring biologic information relating to the subject, and wherein determining a tissue state comprises determining the tissue state from the biologic information, the detected light, and a model relating biologic information, fluorescence and tissue state. 26. A method as in claim 25, wherein the biologic information comprises information from Raman spectroscopic investigation of the subject. 27. A method as in claim 25, wherein the biologic information comprises gender of the individual, height of the individual, weight of the individual, waist circumference of the individual, history of disease in the individual's family, history of gestational diabetes, history of polycystic ovary syndrome, systolic blood pressure, diastolic blood pressure, ethnicity, skin melanin content, blood HDL cholesterol level of the subject, blood LDL cholesterol level of the subject, blood triglycerides level of the subject, laser-Doppler information from the subject's tissue, smoking history of the individual, or a combination thereof. 28. A method as in claim 24, wherein the tissue state determination is substantially insensitive to the present glucose concentration in the subject. 29. A method as in claim 24, wherein the tissue state determination is substantially insensitive to the time since the individual's last meal.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (40)
Ridder, Trent; Maynard, John D.; Abbink, Russell E.; Johnson, Robert D., Apparatus and method for reducing spectral complexity in optical sampling.
Samuels Mark A. (Duluth GA) Patterson Scott W. (Lawrenceville GA) Eppstein Jonathan A. (Atlanta GA) Yu Nai T. (Kowloon HKX) Bursell Sven-Erik (Newton MA), Apparatus and methods for measuring characteristics of biological tissues and similar materials.
Messerschmidt Robert G. (Westport CT) Sting Donald W. (New Canaan CT), Blocker device for eliminating specular reflectance from a diffuse reflection spectrum.
Milosevic Milan (Croton Dam Rd. Fishkill NY) Harrick Nicolas J. (Croton Dam Rd. Ossining NY 10562), Collecting hemispherical attachment for spectrophotometry.
Utzinger, Urs; Durkin, Anthony J.; Fuchs, Holger; Gillenwater, Ann M.; Heintzelman, Douglas L.; Richards-Kortum, Rebecca R., Combined fluorescence and reflectance spectroscopy.
Hull,Edward L.; Ediger,Marwood Neal; Brown,Christopher D.; Maynard,John D.; Johnson,Robert D., Determination of a measure of a glycation end-product or disease state using tissue fluorescence.
Kittrell Carter (Houston TX) Cothren Robert M. (Cleveland Heights OH) Feld Michael S. (Waban MA) Baraga Joseph J. (Somerville MA) An Kyungwon (Cambridge MA) Richards-Kortum Rebecca (Austin TX) Rava R, Method for laser induced fluorescence of tissue.
Robinson Mark R. (Albuquerque NM) Ward Kenneth J. (Albuquerque NM) Eaton Robert P. (Albuquerque NM) Haaland David M. (Albuquerque NM), Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biolo.
Whitehead Peter D.,CAX ; MacAulay Calum E.,CAX ; MacKinnon Nicholas B.,CAX ; Zeng Haishan,CAX ; Thompson Christopher R.,CAX ; McManus Bruce M.,CAX, Methods and apparatus for detecting the rejection of transplanted tissue.
Wong Jacob Y. (4589 Camino Molinero Santa Barbara CA 93110) Formby Bent (1625 Overlook La. Santa Barbara CA 93103) Peterson Charles M. (1075 San Antonio Creek Rd. Santa Barbara CA 93111), Non-invasive quantification of glucose control, aging, and advanced maillard products by stimulated fluorescence.
Deckert Curtis K. ; Hildwein Roger L. ; Wilcox Robert L., Optical probe having and methods for uniform light irradiation and/or light collection over a volume.
Takatani Setsuo (Hyogo JPX) Awau Kunio (Osaka JPX) Kanda Masahiko (Osaka JPX), Reflection type oximeter for applying light pulses to a body tissue to measure oxygen saturation.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.